Luo Z, Zhou F, Tan C, Yin L, Bao M, He X
J Transl Med. 2024; 22(1):1023.
PMID: 39543636
PMC: 11566273.
DOI: 10.1186/s12967-024-05857-6.
Srinivasarao D, Shah S, Famta P, Vambhurkar G, Jain N, Pindiprolu S
Drug Deliv Transl Res. 2024; 15(2):407-435.
PMID: 39037533
DOI: 10.1007/s13346-024-01673-z.
Kwon S, Yang W, Moon D, Kim K
J Cancer. 2020; 11(18):5403-5412.
PMID: 32742487
PMC: 7391204.
DOI: 10.7150/jca.45897.
Gorgisen G, Hapil F, Yilmaz O, Cetin Z, Pehlivanoglu S, Ozbudak I
Genet Mol Biol. 2019; 42(1):15-25.
PMID: 30807634
PMC: 6428125.
DOI: 10.1590/1678-4685-gmb-2017-0307.
Farrar C, Hocking D
J Biol Chem. 2018; 293(48):18655-18666.
PMID: 30323067
PMC: 6290149.
DOI: 10.1074/jbc.RA118.004020.
Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma.
Kitano H, Kitadai Y, Teishima J, Yuge R, Shinmei S, Goto K
Cancer Med. 2017; 6(10):2308-2320.
PMID: 28834289
PMC: 5633586.
DOI: 10.1002/cam4.1124.
Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy.
Higuchi A, Oshima T, Yoshihara K, Sakamaki K, Aoyama T, Suganuma N
Oncol Lett. 2017; 13(2):905-911.
PMID: 28356977
PMC: 5351282.
DOI: 10.3892/ol.2016.5494.
Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy.
Raica M, Cimpean A
Pharmaceuticals (Basel). 2016; 3(3):572-599.
PMID: 27713269
PMC: 4033970.
DOI: 10.3390/ph3030572.
Deficient repair response of IPF fibroblasts in a co-culture model of epithelial injury and repair.
Prasad S, Hogaboam C, Jarai G
Fibrogenesis Tissue Repair. 2014; 7:7.
PMID: 24834127
PMC: 4021590.
DOI: 10.1186/1755-1536-7-7.
Role of receptor tyrosine kinases and their ligands in glioblastoma.
Carrasco-Garcia E, Saceda M, Martinez-Lacaci I
Cells. 2014; 3(2):199-235.
PMID: 24709958
PMC: 4092852.
DOI: 10.3390/cells3020199.
Combining molecular targeted drugs to inhibit both cancer cells and activated stromal cells in gastric cancer.
Onoyama M, Kitadai Y, Tanaka Y, Yuge R, Shinagawa K, Tanaka S
Neoplasia. 2014; 15(12):1391-9.
PMID: 24403861
PMC: 3884530.
DOI: 10.1593/neo.131668.
Targeting the PDGF signaling pathway in tumor treatment.
Heldin C
Cell Commun Signal. 2013; 11:97.
PMID: 24359404
PMC: 3878225.
DOI: 10.1186/1478-811X-11-97.
A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma.
Olanich M, Barr F
Expert Opin Ther Targets. 2013; 17(5):607-23.
PMID: 23432728
PMC: 6699745.
DOI: 10.1517/14728222.2013.772136.
Oxidant signaling for interleukin-13 gene expression in lung smooth muscle cells.
Bansal G, Wong C, Liu L, Suzuki Y
Free Radic Biol Med. 2012; 52(9):1552-9.
PMID: 22370092
PMC: 3341529.
DOI: 10.1016/j.freeradbiomed.2012.02.023.
Immunohistochemical overexpression of platelet-derived growth factor receptor-beta (PDGFR-β) is associated with PDGFRB gene copy number gain in sarcomatoid non-small-cell lung cancer.
Tsao A, Wei W, Kuhn E, Spencer L, Solis L, Suraokar M
Clin Lung Cancer. 2011; 12(6):369-74.
PMID: 21729646
PMC: 3643693.
DOI: 10.1016/j.cllc.2011.02.002.
In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells.
Weigel M, Dahmke L, Schem C, Bauerschlag D, Weber K, Niehoff P
BMC Cancer. 2010; 10:412.
PMID: 20691121
PMC: 2925350.
DOI: 10.1186/1471-2407-10-412.
Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.
Houghton A, Rzymkiewicz D, Ji H, Gregory A, Egea E, Metz H
Nat Med. 2010; 16(2):219-23.
PMID: 20081861
PMC: 2821801.
DOI: 10.1038/nm.2084.
Inhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cells.
Takeuchi H, Kanzawa T, Kondo Y, Kondo S
Br J Cancer. 2004; 90(5):1069-75.
PMID: 14997209
PMC: 2409632.
DOI: 10.1038/sj.bjc.6601605.
Molecular genetic abnormalities in the pathogenesis of human lung cancer.
Forgacs E, Zochbauer-Muller S, Olah E, Minna J
Pathol Oncol Res. 2001; 7(1):6-13.
PMID: 11349214
DOI: 10.1007/BF03032598.
Molecular Events as Targets of Anticancer Drug Therapy.
Aszalos A, Eckhardt S
Pathol Oncol Res. 1997; 3(2):147-158.
PMID: 11173644
DOI: 10.1007/BF02907812.